BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11388023)

  • 1. [Beta 3 adrenergic receptor: physiologic role and potential therapeutic applications].
    Balligand JL
    Bull Mem Acad R Med Belg; 2000; 155(7-9):311-7; discussion 317-9. PubMed ID: 11388023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta(3)-Adrenoceptor agonists: potential, pitfalls and progress.
    Arch JR
    Eur J Pharmacol; 2002 Apr; 440(2-3):99-107. PubMed ID: 12007528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of adipose tissue thermogenesis as a method for increasing energy expenditure.
    Sammons MF; Price DA
    Bioorg Med Chem Lett; 2014 Jan; 24(2):425-9. PubMed ID: 24373722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of an in vivo functional beta 3-adrenoceptor in man.
    Enocksson S; Shimizu M; Lönnqvist F; Nordenström J; Arner P
    J Clin Invest; 1995 May; 95(5):2239-45. PubMed ID: 7738189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors.
    Heubach JF; Blaschke M; Harding SE; Ravens U; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Apr; 367(4):380-90. PubMed ID: 12690430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta 3-adrenoceptors in the cardiovascular system.
    Gauthier C; Sèze-Goismier C; Rozec B
    Clin Hemorheol Microcirc; 2007; 37(1-2):193-204. PubMed ID: 17641409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The negative inotropic action of catecholamines: role of beta3-adrenoceptors.
    Gauthier C; Leblais V; Moniotte S; Langin D; Balligand JL
    Can J Physiol Pharmacol; 2000 Sep; 78(9):681-90. PubMed ID: 11007530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White adipose tissue contributes to UCP1-independent thermogenesis.
    Granneman JG; Burnazi M; Zhu Z; Schwamb LA
    Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1230-6. PubMed ID: 12954594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic response to various beta-adrenoceptor agonists in beta3-adrenoceptor knockout mice: evidence for a new beta-adrenergic receptor in brown adipose tissue.
    Preitner F; Muzzin P; Revelli JP; Seydoux J; Galitzky J; Berlan M; Lafontan M; Giacobino JP
    Br J Pharmacol; 1998 Aug; 124(8):1684-8. PubMed ID: 9756384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Place of beta 3-adrenoceptors among other beta-adrenoceptor subtypes in the regulation of the cardiovascular system.
    Rozec B; Noireaud J; Trochu JN; Gauthier C
    Arch Mal Coeur Vaiss; 2003 Sep; 96(9):905-13. PubMed ID: 14571645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure.
    Erdmann E; Schwinger R; Böhm M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S138-44. PubMed ID: 11527118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On the function of beta3-adrenoceptors in the human heart: signal transduction, inotropic effect and therapeutic prospects].
    Pott C; Steinritz D; Napp A; Bloch W; Schwinger RH; Brixius K
    Wien Med Wochenschr; 2006 Aug; 156(15-16):451-8. PubMed ID: 17041771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology of beta 3-adrenoceptors.
    Lipworth BJ
    Br J Clin Pharmacol; 1996 Sep; 42(3):291-300. PubMed ID: 8877018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased contribution of alpha 1- vs. beta-adrenoceptor-mediated inotropic response in rats with congestive heart failure.
    Sjaastad I; Schiander I; Sjetnan A; Qvigstad E; Bøkenes J; Sandnes D; Osnes JB; Sejersted OM; Skomedal T
    Acta Physiol Scand; 2003 Apr; 177(4):449-58. PubMed ID: 12648162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta3-adrenergic stimulation in the human heart: signal transduction, functional implications and therapeutic perspectives.
    Pott C; Brixius K; Bloch W; Ziskoven C; Napp A; Schwinger RH
    Pharmazie; 2006 Apr; 61(4):255-60. PubMed ID: 16649533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Learning new tricks from old dogs: beta-adrenergic receptors teach new lessons on firing up adipose tissue metabolism.
    Collins S; Cao W; Robidoux J
    Mol Endocrinol; 2004 Sep; 18(9):2123-31. PubMed ID: 15243132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The relationship between beta 3-adrenoceptor and regulation of body fat mass, and food intake].
    Yoshida T; Takakura Y; Sakane N
    Nihon Rinsho; 2001 Mar; 59(3):437-42. PubMed ID: 11268590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of classical (beta1/2-) and atypical beta-adrenoceptors to the stimulation of human white adipocyte lipolysis and right atrial appendage contraction by novel beta3-adrenoceptor agonists of differing selectivities.
    Sennitt MV; Kaumann AJ; Molenaar P; Beeley LJ; Young PW; Kelly J; Chapman H; Henson SM; Berge JM; Dean DK; Kotecha NR; Morgan HK; Rami HK; Ward RW; Thompson M; Wilson S; Smith SA; Cawthorne MA; Stock MJ; Arch JR
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1084-95. PubMed ID: 9618411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brown adipose tissue thermogenesis: β3-adrenoreceptors as a potential target for the treatment of obesity in humans.
    Mund RA; Frishman WH
    Cardiol Rev; 2013; 21(6):265-9. PubMed ID: 23707990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of beta 3-adrenoceptor agonists for the treatment of obesity and diabetes--an update.
    Weyer C; Gautier JF; Danforth E
    Diabetes Metab; 1999 Mar; 25(1):11-21. PubMed ID: 10335419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.